Shu-Feng Zhou Selected Research

MicroRNAs (MicroRNA)

1/2016	miR-3646 promotes cell proliferation, migration, and invasion via regulating G2/M transition in human breast cancer cells.
1/2015	Aptamer-mediated cancer gene therapy.
3/2009	Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shu-Feng Zhou Research Topics

Disease

72	Neoplasms (Cancer) 05/2024 - 01/2006
14	Inflammation (Inflammations) 11/2015 - 06/2009
11	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2006
8	Carcinoma (Carcinomatosis) 05/2023 - 08/2013
8	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 02/2007
7	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 05/2007
6	Drug-Related Side Effects and Adverse Reactions 05/2019 - 03/2006
6	Carcinogenesis 11/2016 - 08/2007
6	Fibrosis (Cirrhosis) 11/2015 - 01/2009
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015 - 01/2015
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2014
5	Leukemia 11/2017 - 01/2014
5	Hypertension (High Blood Pressure) 02/2017 - 05/2008
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 07/2007
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 08/2008
4	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 03/2006
4	Type 2 Diabetes Mellitus (MODY) 12/2015 - 01/2014
4	Body Weight (Weight, Body) 10/2015 - 05/2006
4	Stomach Neoplasms (Stomach Cancer) 01/2015 - 01/2014
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2015 - 03/2009
4	Reperfusion Injury 10/2014 - 01/2008
4	Stroke (Strokes) 06/2008 - 05/2007
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2008 - 05/2007
3	Multiple Organ Failure (MODS) 11/2017 - 11/2013
3	Pancreatitis 11/2017 - 11/2013
3	Abdominal Pain (Pain, Abdominal) 11/2017 - 11/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 01/2015
3	Infections 05/2015 - 10/2006
3	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 01/2015
3	Coronary Disease (Coronary Heart Disease) 06/2008 - 05/2007
3	Central Nervous System Diseases (CNS Diseases) 09/2007 - 04/2007
3	Diarrhea 10/2006 - 05/2006
2	Lung Neoplasms (Lung Cancer) 07/2020 - 08/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2019 - 07/2008
2	Lymphoma (Lymphomas) 11/2016 - 01/2015

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2006
11	p38 Mitogen-Activated Protein KinasesIBA 12/2017 - 01/2015
11	Aurora Kinase AIBA 12/2017 - 01/2015
10	MLN 8237IBA 12/2017 - 01/2015
9	EnzymesIBA 01/2022 - 07/2007
7	Antineoplastic Agents (Antineoplastics)IBA 05/2015 - 12/2007
7	CytokinesIBA 01/2015 - 10/2006
7	plumbaginIBA 01/2015 - 08/2013
7	Irinotecan (Camptosar)FDA LinkGeneric 10/2010 - 05/2006
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 10/2006
6	Biomarkers (Surrogate Marker)IBA 01/2015 - 11/2011
5	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021 - 03/2009
5	danusertibIBA 01/2018 - 01/2015
5	Interleukin-6 (Interleukin 6)IBA 11/2017 - 10/2006
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016 - 01/2006
5	tanshinoneIBA 01/2015 - 05/2007
4	Paclitaxel (Taxol)FDA LinkGeneric 05/2023 - 01/2015
4	SurvivinIBA 12/2020 - 01/2015
4	Aurora KinasesIBA 01/2018 - 01/2015
4	Small Interfering RNA (siRNA)IBA 01/2017 - 01/2012
4	bardoxolone methylIBA 01/2017 - 01/2014
4	Plant ExtractsIBA 11/2015 - 08/2007
3	Glutathione (Reduced Glutathione)IBA 01/2021 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 07/2020 - 01/2014
3	InterleukinsIBA 11/2017 - 01/2012
3	EndotoxinsIBA 11/2017 - 08/2009
3	Epithelial Cell Adhesion MoleculeIBA 01/2017 - 01/2015
3	Interleukin-10 (Interleukin 10)IBA 05/2016 - 11/2013
3	MicroRNAs (MicroRNA)IBA 01/2016 - 03/2009
3	Multidrug Resistance-Associated ProteinsIBA 01/2016 - 02/2008
3	Therapeutic UsesIBA 12/2015 - 01/2015
3	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2015 - 07/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015 - 01/2013
3	Messenger RNA (mRNA)IBA 01/2015 - 05/2007
3	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2015 - 01/2009
3	CyclodextrinsIBA 01/2015 - 01/2013
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2015 - 01/2015
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2015 - 09/2011
3	TOR Serine-Threonine KinasesIBA 01/2015 - 01/2015
3	AntibodiesIBA 01/2015 - 03/2006
3	TriterpenesIBA 01/2015 - 05/2007
3	Beclin-1IBA 01/2015 - 06/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 12/2013
3	ChemokinesIBA 01/2012 - 05/2008
3	Ethanol (Ethyl Alcohol)IBA 01/2010 - 03/2009
3	glabridinIBA 01/2008 - 04/2007
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022 - 10/2014
2	CatalaseIBA 01/2022 - 07/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2009
2	Metal-Organic FrameworksIBA 01/2022 - 01/2021
2	Fluorouracil (Carac)FDA LinkGeneric 12/2020 - 01/2017
2	ImmunosorbentsIBA 07/2019 - 01/2011
2	Cardiac GlycosidesIBA 11/2017 - 05/2015
2	Digoxin (Digitek)FDA LinkGeneric 11/2017 - 05/2015
2	Interleukin-8 (Interleukin 8)IBA 11/2017 - 05/2016
2	Prorenin ReceptorIBA 02/2017 - 11/2015
2	Angiotensin IIIBA 02/2017 - 11/2015
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017 - 10/2006
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/2016 - 11/2013
2	Blood Glucose (Blood Sugar)IBA 05/2016 - 11/2013
2	urinastatin (MR 20)IBA 05/2016 - 11/2013

Therapy/Procedure

34	Therapeutics 05/2024 - 01/2006
18	Drug Therapy (Chemotherapy) 05/2024 - 10/2006
3	Precision Medicine 10/2019 - 12/2013
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2024 - 01/2012